Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01044069
Recruitment Status : Active, not recruiting
First Posted : January 7, 2010
Last Update Posted : February 2, 2021
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):